News & Analysis as of

Sherman Act Deferred Prosecution Agreements

Axinn, Veltrop & Harkrider LLP

Conspiracy Theories Newsletter, 2024 Edition: Eight Predictions for the Future of Cartel Enforcement

2023 was a dramatic year for criminal antitrust enforcement in the United States. The Antitrust Division of the U.S. Department of Justice (“DOJ”) garnered big wins: three convictions at trial,1 $267 million in criminal fines...more

Vinson & Elkins LLP

Winter 2021-2022 Antitrust Cartel Primer

Vinson & Elkins LLP on

This Cartel primer, full document linked below, brings together our knowledge of cartel cases and distills it in an easily digestible and practical format. It discusses challenges targets face in responding to cartel...more

Bradley Arant Boult Cummings LLP

DOJ Secures $100 Million Penalty from Florida Oncology Provider for Criminal Antitrust Conspiracy

On April 30, 2020, the United States Department of Justice Antitrust Division (DOJ) announced that it had brought a one-count felony charge against Florida Cancer Specialists & Research Institute LLC (FCS), an oncology group...more

Seyfarth Shaw LLP

First, Do No Harm: Oncology Group Agrees to $100M Fine Following Criminal Antitrust Investigation

Seyfarth Shaw LLP on

The Department of Justice recently announced that it had charged one of the largest independent oncology groups in the country, Florida Cancer Specialists & Research Institute LLC (“FCS”), with antitrust violations under the...more

Morgan Lewis - Health Law Scan

Florida Oncology Group Pays $100M Fine, Enters into DPA with DOJ Antitrust Over Alleged Market Allocation Agreement

The Antitrust Division of the US Department of Justice (DOJ) entered into a deferred prosecution agreement (DPA) with Florida Cancer Specialists & Research Institute LLC (FCS), a leading oncology provider in Southwest...more

King & Spalding

Florida Oncology Provider to Pay $100 Million Fine in DOJ Criminal Antitrust Investigation

King & Spalding on

On Thursday, April 30, 2020, Florida Cancer Specialists & Research Institute LLC (“FCS”), the largest independent medical oncology/hematology practice in the U.S., agreed to pay a $100 million fine to resolve a criminal...more

Bass, Berry & Sims PLC

New DOJ Policy Underscores Need for Effective and Robust Antitrust Compliance Programs Now More than Ever | Bass, Berry & Sims PLC

Bass, Berry & Sims PLC on

• The Department of Justice (DOJ) has announced a policy change under which it will consider a company’s antitrust compliance program in mitigation of alleged criminal violations of antitrust laws. • The DOJ’s previous...more

7 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide